このエントリーをはてなブックマークに追加


ID 69790
フルテキストURL
著者
Tanaka, Takaaki Department of Respiratory Medicine, Okayama University Hospital
Makimoto, Go Department of Respiratory Medicine, Okayama University Hospital
Sumii, Ryohei Department of General Internal Medicine, NHO Fukuyama Medical Center
Omote, Rika Department of Pathology, NHO Fukuyama Medical Center
Ando, Yayoi Clinical Research Support Office, National Cancer Center Hospital
Ninomiya, Kiichiro Center for Comprehensive Genomic Medicine, Okayama University Hospital Kaken ID
Ichihara, Eiki Center for Clinical Oncology, Okayama University Hospital Kaken ID publons
Ohashi, Kadoaki Department of Respiratory Medicine, Okayama University Hospital ORCID Kaken ID researchmap
Maeda, Yoshinobu Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Kaken ID researchmap
Tabata, Masahiro Center for Clinical Oncology, Okayama University Hospital Kaken ID researchmap
抄録
This case report describes a 70-year-old female with cancer of unknown primary origin (CUP) who exhibited multiple distant lymph node metastases. Despite conventional chemotherapy (carboplatin and paclitaxel) and immunotherapy (nivolumab), disease progression was noted. Genomic profiling revealed MET amplification, leading to the administration of capmatinib, a selective MET tyrosine kinase inhibitor. The patient experienced substantial tumor reduction with dose adjustments due to adverse effects, indicating the potential efficacy of capmatinib in treating CUP with MET amplification.
キーワード
MET amplification
capmatinib
MET inhibitors
cancer of unknown primary
MET exon 14 skipping
発行日
2025-12-01
出版物タイトル
Internal Medicine
64巻
23号
出版者
Japanese Society of Internal Medicine
開始ページ
3460
終了ページ
3464
ISSN
0918-2918
NCID
AA10827774
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© 2025 by The Japanese Society of Internal Medicine
論文のバージョン
publisher
PubMed ID
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.2169/internalmedicine.5028-24
ライセンス
https://creativecommons.org/licenses/by-nc-nd/4.0/